HEB - .515 Pre-market now at .61/.64 Hemispherx Updates Status of Immuno-Oncology Program in Pancreatic Cancer http://stockcharts.com/c-sc/sc?s=HEB&p=D&b=5&g=0&i=t84453440039&r=1499692675372 http://stockcharts.com/c-sc/sc?s=HEB&p=W&b=5&g=0&i=t05633310373&r=1499692624478